Lyfulyst Trademark Details

This mark is alive with a status of Notice of Allowance - Issued. The last case file activity for this mark occured 7 years ago on Tuesday, September 20, 2016, according to the United State Patent & Trademark Office

Word Mark	Lyfulyst
Status	Alive 688 — Notice of Allowance - Issued

Current Owner

Eli Lilly and Company of Indianapolis, IN

View all trademarks for Eli Lilly and Company

Other Trademarks for Eli Lilly and Company

Serial Number	86935472
Status Date	Tuesday, September 20, 2016
Filing Date	Tuesday, September 20, 2016
Attorney	Bruce W. Longbottom

Correspondent

BRUCE W. LONGBOTTOM
ELI LILLY AND COMPANY
LILLY CORPORATE CENTER
INDIANAPOLIS, IN 46285

Case File Statements

Goods & Services	Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anemia, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anemia, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classifications

International Class Codes	005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes	006, 018, 044, 046, 051, 052
Status	6 — Active
Status Date	Tuesday, March 15, 2016
Primary Code	005

Trademark Timeline

Mar 10 2016

Trademark application filed with USPTO
Mar 14 2016

New Application Entered In Tram
Mar 15 2016

New Application Office Supplied Data Entered In Tram
Jun 15 2016

Approved For Pub - Principal Register
Jun 15 2016

Assigned To Examiner
Jul 06 2016

Notification of Notice of Publication E-Mailed
Jul 26 2016

Official Gazette Publication Confirmation E-Mailed
Jul 26 2016

Published For Opposition
Sep 20 2016

Noa E-Mailed - Sou Required From Applicant